Tarsus Pharmaceuticals Inc.
TARS | NASDAQ
$77.46
-$0.63 (-0.81%)
At close: Sep 21, 2026, 4:00 PM ET
$77.46
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -18.55M | -6.97M | -8.37M | -12.59M | -20.34M | -25.12M | -23.11M | -23.42M | -33.29M | -35.73M | -41.9M | -39.15M | -31.42M | -23.42M | -13.6M | -22.51M | -5.74M | -20.24M | -14.85M | -15.7M | 6.35M | 10.38M |
Depreciation & Amortization | 1M | 437K | 443K | 400K | 453K | 460K | 432K | 284K | 239K | 270K | 347K | 244K | 182K | 104K | 98K | 94K | 92K | 41K | 40K | 83K | 125K | 64K |
Stock-Based Compensation | 13.29M | 11.97M | 14.31M | 12.24M | 8.23M | 6.93M | 7.4M | 7.42M | 7.48M | 5.52M | 5.48M | 5.25M | 5.19M | 3.91M | 3.67M | 3.58M | 3.53M | 2.67M | 2.18M | 2.12M | 2.79M | 1.36M |
Other Working Capital | n/a | -6.9M | 57.42M | 9.55M | -21.39M | 2.96M | -3.25M | -7.47M | 3.34M | -6.35M | 3.57M | 1.73M | 35K | -1.03M | 22K | 2.11M | -322K | -321K | -366K | 21.27M | 190.45M | -1.81M |
Other Non-Cash Items | 36.01M | -613K | -629K | -1.13M | -1.38M | -1.01M | -1.18M | 8.73M | 914K | 742K | -455K | -113K | -891K | -1.15M | -1.13M | 179K | 571K | 606K | 474K | 91K | 44K | 5.57M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 350K | 903K | n/a |
Change in Working Capital | 35.02M | -29.48M | 13.58M | 19.33M | -16.36M | -1.91M | -5.73M | -1.66M | 10.25M | -8.59M | -2.81M | 1.41M | 3.12M | -1.41M | 85K | 44K | -2.71M | 1.63M | 37K | 20.17M | 10.34M | -29.17M |
Operating Cash Flow | 66.77M | -24.65M | 19.33M | 18.26M | -29.39M | -20.65M | -22.18M | -8.65M | -14.4M | -37.79M | -39.34M | -32.36M | -23.83M | -21.97M | -10.87M | -18.61M | -4.26M | -15.29M | -12.12M | 7.11M | 20.55M | -11.79M |
Capital Expenditures | -4.07M | -5.82M | -6.36M | -1.91M | -1M | -590K | -5.07M | -282K | -1.04M | -174K | n/a | -4.38M | -787K | -340K | -127K | -96K | -122K | -161K | -274K | -121K | -16K | -175K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -2.4M | -126.8M | -36.45M | -102.33M | -129.7M | -125.57M | -89.97M | -24.09M | -50.03M | -104.55M | n/a | 3K | n/a | -28.67M | -92.41M | -57.03M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 44.35M | 74.06M | 92.08M | 99.5M | 79M | 91.22M | 35.47M | 24.5M | 10.54M | 2.5M | 17.85M | 51.74M | 64.88M | 40.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | -5M | 3M | n/a | n/a | n/a | -4M | n/a | n/a | 5.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 37.88M | -58.56M | 49.27M | -4.74M | -51.7M | -34.94M | -59.57M | 3.13M | -40.53M | -102.22M | 17.85M | 47.37M | 64.09M | 11.29M | -87.22M | -57.13M | -122K | -161K | -274K | -121K | -16K | -175K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | -31.88M | -39K | 71.52M | n/a | n/a | 5M | n/a | 5M | n/a | n/a | -60K | 19.19M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.3M | n/a | n/a | n/a | n/a | n/a | 31.88M | n/a | -31.88M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 3.54M | 1.2M | 2.31M | 2.56M | 1.95M | 136.56M | 2.93M | 639K | 42.32M | 108.77M | 19.76M | 104.89M | 510K | 5.01M | 264K | -136K | 74.73M | 19.13M | -74K | 75K | 1K | 19K |
Net Cash Flow | 108.18M | -82.01M | 70.92M | 16.08M | -79.14M | 80.97M | -78.83M | -4.89M | -12.61M | -31.24M | -1.73M | 119.9M | 40.78M | -5.66M | -97.83M | -75.87M | 70.35M | 3.68M | -12.47M | 7.07M | 20.54M | -11.95M |
Free Cash Flow | 62.7M | -30.47M | 12.97M | 16.35M | -30.39M | -21.24M | -27.25M | -8.93M | -15.44M | -37.96M | -39.34M | -36.74M | -24.61M | -22.31M | -11M | -18.71M | -4.38M | -15.45M | -12.4M | 6.99M | 20.54M | -11.97M |
Adj. Free Cash Flow | 49.41M | -42.44M | -1.34M | 4.1M | -38.62M | -28.17M | -34.66M | -16.35M | -22.92M | -43.48M | -44.82M | -41.99M | -29.81M | -26.22M | -14.67M | -22.29M | -7.91M | -18.12M | -14.57M | 4.87M | 17.74M | -13.33M |
Maintenance CapEx | -1M | -437K | -2.55M | n/a | n/a | n/a | -2.98M | n/a | n/a | n/a | n/a | -4.22M | -787K | -179.06K | n/a | -96K | -122K | -161K | -254.14K | -48.14K | n/a | n/a |
Growth CapEx | -3.07M | -5.38M | -3.81M | -1.91M | -1M | -590K | -2.09M | -282K | -1.04M | -174K | n/a | -153.55K | n/a | -160.94K | -127K | n/a | n/a | n/a | -19.86K | -72.86K | -16K | -175K |
Owner Earnings | 65.77M | -25.09M | 16.78M | 18.26M | -29.39M | -20.65M | -25.16M | -8.65M | -14.4M | -37.79M | -39.34M | -36.58M | -24.61M | -22.15M | -10.87M | -18.71M | -4.38M | -15.45M | -12.38M | 7.06M | 20.55M | -11.79M |
Add to Watchlist
Select watchlists to add or remove TARS